StonvexLoading…
StonvexStonvexStonvexCore line items from ADSK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-30 | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 |
|---|---|---|---|---|
Revenue | $1.93B | $7.21B | $5.25B | $3.40B |
Operating Income | $541.00M | $1.58B | $1.15B | $677.00M |
Net Income | $491.00M | $1.12B | $808.00M | $313.00M |
EPS (Diluted) | $2.32 | $5.23 | $3.76 | $2.15 |
Total Assets | $11.93B | $12.47B | $11.20B | $10.86B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.67B | $2.25B | $1.99B | $2.00B |
Free Cash Flow OCF − CapEx | $876.00M | $2.41B | $1.44B | $1.01B |
Shares Outstanding | 212.00M | 212.00M | 215.00M | 216.00M |